In‐Situ Dynamic Chemical Reconstruction Synthesis of Dual‐Antioxidants for Pulmonary Arterial Hypertension Treatment
- 29 September 2026
- journal article
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 65 (46) , e8724742
Abstract
Pulmonary arterial hypertension (PAH) is a serious circulatory system disease characterized by redox imbalance, which results from the overexpressed reactive oxygen species (ROS) and inactivated antioxidation defense system. In this work, a dynamic chemical reconstruction strategy has been developed for PAH treatment through the in situ synthesis of antioxidant nanocatalyst MoO y and selenium oxyanions from a molybdenum selenide nanosystem in response to the oxidative microenvironment of PAH. MoO y nanoparticles catalyze the exogenous antioxidation reactions to scavenge ROS efficiently, while the soluble selenium oxyanions upregulate the expression of selenoproteins to reinforce the endogenous antioxidant defense system. These two processes cooperatively alleviate oxidative stress of pulmonary artery smooth muscle cells (PASMCs), thus suppressing their malignant proliferation/migration and finally mitigating pulmonary arterial remodeling for PAH treatment. This work presents a dynamic chemical reconstruction strategy for in situ synthesis of exogenous and endogenous antioxidants, offering a dual‐axis antioxidation approach for the treatment of multiple redox imbalance‐associated diseases.Keywords
Funding Information
- National Natural Science Foundation of China (T2495260‐T2495263)
- National Natural Science Foundation of China (22335006)
- National Natural Science Foundation of China (22305260)
This publication has 29 references indexed in Scilit:
- Generalized concept of catalysis for chemical reactions: Nanocatalysis in medicine as a paradigmChem, 2025
- Antioxidative Therapy of Alcoholic Liver Injury by Amorphous Two‐Dimensional Cobalt Hydroxide NanocatalystAngewandte Chemie International Edition, 2024
- Pulmonary artery smooth muscle cell phenotypic switching: A key event in the early stage of pulmonary artery hypertensionDrug Discovery Today, 2023
- Diagnosis and Treatment of Pulmonary Arterial HypertensionJAMA, 2022
- Nanocatalytic MedicineAdvanced Materials, 2019
- Selenium‐Based Nanozyme as Biomimetic Antioxidant MachineryChemistry – A European Journal, 2018
- Selenium Utilization by GPX4 Is Required to Prevent Hydroperoxide-Induced FerroptosisCell, 2018
- Synergistic Phase and Disorder Engineering in 1T‐MoSe2 Nanosheets for Enhanced Hydrogen‐Evolution ReactionAdvanced Materials, 2017
- Peptide-Directed Highly Selective Targeting of Pulmonary Arterial HypertensionThe American Journal of Pathology, 2011
- Anti-oxidants for therapeutic use: Why are only a few drugs in clinical use?Advanced Drug Delivery Reviews, 2009